Medi Caps Ltd

MEDICAPS

Watchlist

AI Mode

‌

Market Cap

₹ 40 Cr

P/E

—

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

UNDERVALUED

Growth

STABLE

Profitability

LOW MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Medi-caps Ltd., founded in 1983, is the second-largest manufacturer of empty hard gelatine capsules in India, serving major pharmaceutical companies for oral medications.

The company achieved notable manufacturing milestones, including zero-defect production and full operation normalization, reflecting its industry expertise and quality control.

Medi-caps discontinued its capsule production in 2019 and has transitioned into real estate with the Medicaps Business Park project initiated in partnership with Tirupati Reality & Developers.

Historically, the company expanded its manufacturing capabilities significantly and entered the export markets of several countries, showcasing its previous industry reach.

The company's foray into real estate marks a transformative shift from its pharmaceutical manufacturing origins, indicating strategic diversification.

Sector

Realty

Industry

Construction - Factories / Offices / Commercial

Market Cap

40 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

35.8

PEG Ratio

—

P/B Ratio

0.3

52W High

61.00

52W Low

31.00

Sales CAGR

-6.84%

—

-28.48%

10Y

-23.75%

Profit CAGR

74.55%

—

10Y

-8.06%

ROE

TTM

-4.84%

-0.29%

3.46%

10Y

2.24%

ROCE

TTM

-5.04%

0.79%

4.12%

10Y

2.72%

Technicals

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SISL	236.15	45 Cr	8.41	4.13	0.00	43.31	57.44	47.78
PARLEIND	9.00	44 Cr	—	0.30	0.00	-0.09	0.08	-0.08
GOTHIPL	40.00	42 Cr	24.26	3.41	4.85	14.08	14.15	9.45
KONTOR	63.10	41 Cr	9.90	1.56	0.00	15.71	15.52	10.98
MEDICAPS	31.57	40 Cr	—	0.34	0.00	-4.84	-5.04	-4.65
BHANDERI	153.00	40 Cr	30.78	1.51	0.00	4.28	2.73	1.76
MPDL	42.61	34 Cr	—	0.36	0.00	-6.68	-4.86	-3.84

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	6.38	6.03	7.07	7.87	6.19	8.30	4.02	6.96	2.69	2.01
Expenses	7.11	5.54	6.37	8.37	6.48	7.84	5.80	7.19	6.06	4.92
Operating Profit	-0.73	0.49	0.70	-0.50	-0.29	0.46	-1.78	-0.23	-3.37	-2.91
OPM %	-11.44	8.13	9.90	-6.35	-4.68	5.54	-44.28	-3.30	-125.28	-144.78
Other Income	0.07	0.07	0.09	0.24	0.15	0.29	0.16	2.14	0.33	1.53
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.00
Depreciation	0.45	0.45	0.45	0.33	0.42	0.43	0.43	0.44	0.44	0.44
Profit Before Tax	-1.11	0.12	0.34	-0.59	-0.56	0.31	-2.05	1.45	-3.49	-1.82
Tax %	0.00	0.00	150.00	-83.05	0.00	0.00	0.00	-18.62	0.00	0.00
Net Profit	-1.11	0.12	-0.16	-1.08	-0.56	0.31	-2.05	1.72	-3.49	-1.82
EPS in Rs	-0.89	0.09	-0.13	-0.86	-0.45	0.25	-1.64	1.38	-2.80	-1.46

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	47	50	55	45	59	70	49	27	25	25
Expenses	43	48	47	50	47	60	44	27	27	27
Operating Profit	4.05	2.56	8.28	-4.86	12	9.96	5.06	-0.03	-1.83	-1.84
OPM %	8.69	5.09	14.93	-10.80	20.74	14.25	10.25	-0.13	-7.17	-7.22
Other Income	2.03	1.07	2.73	2.87	0.58	1.91	1.60	0.48	2.73	2.74
Interest	0.01	0.01	0.02	0.02	0.00	0.00	0.00	0.00	0.02	0.02
Depreciation	1.81	1.79	1.82	1.83	1.52	1.81	1.74	1.69	1.72	1.72
Profit Before Tax	1.72	1.35	5.50	-5.84	11	10	4.92	-1.25	-0.84	-0.85
Tax %	20.53	14.85	2.12	-0.14	-0.05	0.14	62.07	-79.84	32.11	31.76
Net Profit	1.37	1.15	5.39	-5.85	11	10	1.87	-2.24	-0.57	-0.58
EPS in Rs	—	—	—	-3.47	11.09	8.60	0.82	-1.79	-0.46	-4.52
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	12	12	12	12	12	12	12	12	12	12
Reserves	70	77	78	83	78	92	104	106	109	109
Borrowings	0.08	0.09	0.17	0.12	0.06	0.00	0.00	0.00	0.00	0.00
Other Liabilities	11	8.20	11	11	4.19	10	14	7.42	6.30	4.15
Total Liabilities	93	97	101	107	95	115	130	126	127	125
Fixed Assets	56	61	60	59	57	58	59	59	58	56
CWIP	0.00	0.00	0.00	0.00	0.97	0.54	0.24	0.00	0.00	0.08
Investments	6.74	8.91	12	17	22	29	31	32	39	44
Other Assets	30	27	29	30	15	27	40	35	30	25
Total Assets	93	97	101	107	95	115	130	126	127	125

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	2.59	4.02	4.20	5.96	4.63	15	7.02	-6.08	6.94	5.07
Cash from Investing Activity	-1.47	2.57	-4.09	-5.75	-5.80	-9.70	-4.08	-2.56	-7.73	-4.98
Cash from Financing Activity	-0.73	-5.76	0.08	-0.05	-0.06	-0.06	0.00	0.00	0.00	0.00
Net Cash Flow	0.39	0.83	0.20	0.16	-1.23	5.56	2.95	-8.64	-0.79	0.09

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	50.13%	50.13%	50.13%	50.13%	50.13%	50.13%	50.13%	50.43%	50.62%	50.77%	50.77%	50.77%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Public	49.84%	49.84%	49.84%	49.84%	49.84%	49.84%	49.84%	49.54%	49.36%	49.20%	49.20%	49.20%
Total Shareholders	16,114	15,308	14,566	13,790	13,226	12,356	11,738	11,255	11,176	11,033	10,851	10,692

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Jan 08, 2025	Manju gaggar	Bulk	Buy	57.41	0.72 Cr	1,25,000	1.00
Apr 05, 2024	Dheeraj kumar lohia	Bulk	Buy	50.03	0.40 Cr	79,371	0.63
Apr 05, 2024	Gopal krishna maheshwari	Bulk	Sell	50.48	0.44 Cr	86,519	0.69
Mar 03, 2023	Kanwarinderpal sahni	Bulk	Buy	38.37	0.24 Cr	62,449	0.50
Mar 03, 2023	Kanwarinderpal sahni	Bulk	Sell	39.70	0.00 Cr	98	0.00

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Overview

Detailed Summary

Medi-caps Ltd., founded in 1983, is the second-largest manufacturer of empty hard gelatine capsules in India, serving major pharmaceutical companies for oral medications.

The company achieved notable manufacturing milestones, including zero-defect production and full operation normalization, reflecting its industry expertise and quality control.

Medi-caps discontinued its capsule production in 2019 and has transitioned into real estate with the Medicaps Business Park project initiated in partnership with Tirupati Reality & Developers.

Historically, the company expanded its manufacturing capabilities significantly and entered the export markets of several countries, showcasing its previous industry reach.

The company's foray into real estate marks a transformative shift from its pharmaceutical manufacturing origins, indicating strategic diversification.

Sector

Realty

Industry

Construction - Factories / Offices / Commercial

Market Cap

40 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

35.8

PEG Ratio

—

P/B Ratio

0.3

52W High

61.00

52W Low

31.00

Sales CAGR

-6.84%

—

-28.48%

10Y

-23.75%

Profit CAGR

74.55%

—

10Y

-8.06%

ROE

TTM

-4.84%

-0.29%

3.46%

10Y

2.24%

ROCE

TTM

-5.04%

0.79%

4.12%

10Y

2.72%

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	6.38	6.03	7.07	7.87	6.19	8.30	4.02	6.96	2.69	2.01
Expenses	7.11	5.54	6.37	8.37	6.48	7.84	5.80	7.19	6.06	4.92
Operating Profit	-0.73	0.49	0.70	-0.50	-0.29	0.46	-1.78	-0.23	-3.37	-2.91
OPM %	-11.44	8.13	9.90	-6.35	-4.68	5.54	-44.28	-3.30	-125.28	-144.78
Other Income	0.07	0.07	0.09	0.24	0.15	0.29	0.16	2.14	0.33	1.53
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.00
Depreciation	0.45	0.45	0.45	0.33	0.42	0.43	0.43	0.44	0.44	0.44
Profit Before Tax	-1.11	0.12	0.34	-0.59	-0.56	0.31	-2.05	1.45	-3.49	-1.82
Tax %	0.00	0.00	150.00	-83.05	0.00	0.00	0.00	-18.62	0.00	0.00
Net Profit	-1.11	0.12	-0.16	-1.08	-0.56	0.31	-2.05	1.72	-3.49	-1.82
EPS in Rs	-0.89	0.09	-0.13	-0.86	-0.45	0.25	-1.64	1.38	-2.80	-1.46

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	47	50	55	45	59	70	49	27	25	25
Expenses	43	48	47	50	47	60	44	27	27	27
Operating Profit	4.05	2.56	8.28	-4.86	12	9.96	5.06	-0.03	-1.83	-1.84
OPM %	8.69	5.09	14.93	-10.80	20.74	14.25	10.25	-0.13	-7.17	-7.22
Other Income	2.03	1.07	2.73	2.87	0.58	1.91	1.60	0.48	2.73	2.74
Interest	0.01	0.01	0.02	0.02	0.00	0.00	0.00	0.00	0.02	0.02
Depreciation	1.81	1.79	1.82	1.83	1.52	1.81	1.74	1.69	1.72	1.72
Profit Before Tax	1.72	1.35	5.50	-5.84	11	10	4.92	-1.25	-0.84	-0.85
Tax %	20.53	14.85	2.12	-0.14	-0.05	0.14	62.07	-79.84	32.11	31.76
Net Profit	1.37	1.15	5.39	-5.85	11	10	1.87	-2.24	-0.57	-0.58
EPS in Rs	—	—	—	-3.47	11.09	8.60	0.82	-1.79	-0.46	-4.52
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	12	12	12	12	12	12	12	12	12	12
Reserves	70	77	78	83	78	92	104	106	109	109
Borrowings	0.08	0.09	0.17	0.12	0.06	0.00	0.00	0.00	0.00	0.00
Other Liabilities	11	8.20	11	11	4.19	10	14	7.42	6.30	4.15
Total Liabilities	93	97	101	107	95	115	130	126	127	125
Fixed Assets	56	61	60	59	57	58	59	59	58	56
CWIP	0.00	0.00	0.00	0.00	0.97	0.54	0.24	0.00	0.00	0.08
Investments	6.74	8.91	12	17	22	29	31	32	39	44
Other Assets	30	27	29	30	15	27	40	35	30	25
Total Assets	93	97	101	107	95	115	130	126	127	125

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	2.59	4.02	4.20	5.96	4.63	15	7.02	-6.08	6.94	5.07
Cash from Investing Activity	-1.47	2.57	-4.09	-5.75	-5.80	-9.70	-4.08	-2.56	-7.73	-4.98
Cash from Financing Activity	-0.73	-5.76	0.08	-0.05	-0.06	-0.06	0.00	0.00	0.00	0.00
Net Cash Flow	0.39	0.83	0.20	0.16	-1.23	5.56	2.95	-8.64	-0.79	0.09

Medi Caps Ltd

Medi Caps Ltd

MEDICAPS

AI Mode

Investment Checklist

Investment Checklist

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Technicals

Oscillators

Neutral

Overall

Bearish

Moving Averages

Bearish

Overall

Bearish

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Projection

Actions

Announcements

Documents

AI Mode

AI Mode

Overview

Sector

Industry

Market Cap

Volatility

P/E Ratio

Industry P/E

PEG Ratio

P/B Ratio

52W High

52W Low

Medi Caps Ltd

MEDICAPS

AI Mode

Financial Statements

AI Powered Summary

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

Consolidated Profit Loss (in ₹ Crores)

Consolidated Balance Sheet (in ₹ Crores)

Consolidated Cash Flows (in ₹ Crores)

Peers

Price Chart Comparison

Investment Checklist

Announcements